Drugs / asparaginase (Erwina)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00165087 | Jan 1996 → Sep 2006 | childhood acute lymphoblastic leukemia | Dana-Farber Cancer Institute | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | asparaginase (Erwina) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00165087 ↗ |